Page 28 - Astrazeneca

Race for coronavirus cure hits reality as clinic complications mount

Regulators and drugmakers have faced questions about whether political pressure was overwhelming scientific rigor ahead of the presidential election on Nov. 3

AstraZeneca's Covid-19 antibody drug heads into final testing stage

The drug will be evaluated for its ability to prevent infections for up to a year in some people and as a preemptive medicine once patients have been exposed to the virus in others

Inhaled vaccines aim to target coronavirus at its point of invasion

Most vaccines in human testing require two shots for effectiveness, and developers still aren't even sure if they'll prevent infections

US, AstraZeneca strike deal for Covid-19 antibody treatment touted by Trump

The US government has awarded $486 mn to AstraZeneca Plc to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment

AstraZeneca could profit from Covid-19 vaccine as early as July: Report

AstraZeneca could start profiting from its Covid-19 vaccine as soon as July next year, the Financial Times reported

AstraZeneca's Japanese Covid-19 vaccine trial back up, US still paused

Clinical trials of AstraZeneca and Oxford University's experimental Covid-19 vaccine have resumed in Japan, almost a month after being put on hold, while discussions with US authorities continue

ICMR launches a new vaccine portal for Covid, with details of trials

The portal covers other ailments as well; will provide details of progress made locally and globally at regular intervals

ICMR exploring saliva-based tests to diagnose Covid-19: Harsh Vardhan

Vardhan also said that no significant or drastic mutations had been found in strains of SARS-CoV-2 in India till now

World Coronavirus Dispatch: World economy to shrink 4.5% this yr, says OECD

The better view reflects the strong economic pickup in recent months and the vast injection of public resources

Govt in talks with Russia for advancement of Covid-19 vaccine: Health Min

The Central Drugs Standard Control Organisation (CDSCO) has informed that it has received information about one Covid-19 vaccine developed and approved in Russia

USFDA's Hahn plans significant work with AstraZeneca in Covid trial inquiry

The top US Food and Drug Administration official confirmed AstraZeneca's US Covid-19 vaccine trial is on hold

Some volunteers quit J&J Covid-19 trial in Spain after AstraZeneca scare

MADRID (Reuters) - Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.

WHO praises AstraZeneca for pausing coronavirus vaccine global trial

A WHO official on Tuesday said that the decision by AstraZeneca to pause global trials of its experimental coronavirus vaccine after an unexplained illness showed the firm was prioritising safety

AstraZeneca coronavirus vaccine trial in US on hold until midweek: Report

AstraZeneca on Saturday said it had restarted its trial in Britain after regulators completed their review of a serious side effect in one trial participant there

Not enough Covid-19 vaccines for everybody till 2024 end: Adar Poonawalla

Poonawalla estimates that the world will need 15 billion doses of the vaccine if it is taken in two steps

AstraZeneca-Oxford's coronavirus vaccine trials resume in Brazil

AstraZeneca paused global trials temporarily last week after an unexplained illness in a participant in Britain.

AstraZeneca resumes Oxford Covid vaccine trial after UK green signal

The late-stage trials of the experimental vaccine, one of the most advanced in development, were suspended this week after an illness in a study subject in Britain

DCGI aks Serum Institute to suspend recruitment for Oxford vaccine trials

DCGI has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate

Top headlines: AstraZeneca still aiming for vaccine; MGNREGS fund drying up

From India awaiting drug regulator's nod to restart the vaccine trial to drying up MGNREGA funds, here are top headlines this morning

AstraZeneca still aiming for Oxford Covid-19 vaccine by year-end, says CEO

Soriot sought to reassure investors after the company and its partner confirmed earlier this week that they had temporarily stopped giving people the experimental shot